Schmidt H - Search Results

1

Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors.

Würl P, Taubert H, Bache M, Kroll J, Meye A, Berger D, Siermann A, Holzhausen HJ, Hinze R, Schmidt H, Rath FW. Würl P, et al. Among authors: schmidt h. Int J Cancer. 1996 Aug 22;69(4):317-23. doi: 10.1002/(SICI)1097-0215(19960822)69:4<317::AID-IJC14>3.0.CO;2-2. Int J Cancer. 1996. PMID: 8797875

2

Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis.

Bartel F, Schulz J, Böhnke A, Blümke K, Kappler M, Bache M, Schmidt H, Würl P, Taubert H, Hauptmann S. Bartel F, et al. Among authors: schmidt h. Int J Cancer. 2005 Nov 10;117(3):469-75. doi: 10.1002/ijc.21206. Int J Cancer. 2005. PMID: 15906355

3

Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients.

Taubert HW, Bartel F, Kappler M, Schuster K, Meye A, Lautenschläger C, Thamm-Mücke B, Bache M, Schmidt H, Holzhausen HJ, Würl P. Taubert HW, et al. Among authors: schmidt h. Cancer. 2003 May 1;97(9):2273-8. doi: 10.1002/cncr.11326. Cancer. 2003. PMID: 12712483 Free article.

4

Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies.

Würl P, Taubert H, Meye A, Berger D, Lautenschläger C, Holzhausen HJ, Schmidt H, Kalthoff H, Rath FW, Dralle H. Würl P, et al. Among authors: schmidt h. J Cancer Res Clin Oncol. 1997;123(9):502-8. doi: 10.1007/BF01192205. J Cancer Res Clin Oncol. 1997. PMID: 9341900

5

How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone?

Taubert H, Berger D, Hinze R, Meye A, Würl P, Hogendoorn PC, Holzhausen HJ, Schmidt H, Rath FW. Taubert H, et al. Among authors: schmidt h. Cancer Lett. 1998 Jan 30;123(2):147-51. doi: 10.1016/s0304-3835(97)00423-0. Cancer Lett. 1998. PMID: 9489481

6

The p53 gene in soft tissue sarcomas: prognostic value of DNA sequencing versus immunohistochemistry.

Taubert H, Würl P, Bache M, Meye A, Berger D, Holzhausen HJ, Hinze R, Schmidt H, Rath FW. Taubert H, et al. Among authors: schmidt h. Anticancer Res. 1998 Jan-Feb;18(1A):183-7. Anticancer Res. 1998. PMID: 9568075

7

No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas.

Meye A, Würl P, Hinze R, Berger D, Bache M, Schmidt H, Rath FW, Taubert H. Meye A, et al. Among authors: schmidt h. J Pathol. 1998 Jan;184(1):14-7. doi: 10.1002/(SICI)1096-9896(199801)184:1<14::AID-PATH957>3.0.CO;2-K. J Pathol. 1998. PMID: 9582521

8

Molecular characterization and liposomal transfection of a p53-mutated cell line established from a poorly differentiated leiomyosarcoma.

Meye A, Bache M, Hinze R, Schmidt H, Würl P, Holzhausen HJ, Rath FW, Taubert H. Meye A, et al. Among authors: schmidt h. Int J Oncol. 1998 Aug;13(2):241-8. doi: 10.3892/ijo.13.2.241. Int J Oncol. 1998. PMID: 9664117

9

p53 status in radiation-induced soft-tissue sarcomas.

Taubert H, Meye A, Bache M, Hinze R, Holzhausen HJ, Schmidt H, Rath FW, Dunst J, Würl P. Taubert H, et al. Among authors: schmidt h. Strahlenther Onkol. 1998 Aug;174(8):427-30. doi: 10.1007/BF03038565. Strahlenther Onkol. 1998. PMID: 9739384

10

[Frequency, distribution and prognostic relevance of p53 mutations in soft tissue sarcomas].

Taubert H, Würl P, Meye A, Bache M, Kroll J, Lautenschläger C, Thamm B, Holzhausen HJ, Hinze R, Schmidt H, Berger D, Rath FW. Taubert H, et al. Among authors: schmidt h. Verh Dtsch Ges Pathol. 1998;82:340-4. Verh Dtsch Ges Pathol. 1998. PMID: 10095457 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,423 results

Search Page

Filters